Contact Us
Back to Events
  • Published 20 Mar 2023

CatSci To Attend BioTrinity London 2023 

  • Events

CatSci Ltd, an award-winning innovation partner for medicines development, will be attending BioTrinity London 2023. Taking place on 25th – 26th April 2023, BioTrinity encourages growth and engagement in the life sciences industry.  

Our CEO, Dr Ross Burn, and our Head of Customer Acquisition, Jenn Clark, will be attending this established London conference. They are looking forward to engaging with the industry and exploring how CatSci can support your drug development needs.  

To book a meeting with Ross and Jenn, please get in touch here.  

Resources & Insights

Explore resources hub
  • 12 Jun 2026
  • Joseph Renny, Simon N. G. Tyler
From Undruggable to Inevitable: Fifteen years of drug development — and what comes next 
  • Artificial Intelligence (AI)
  • Process R&D
  • Thought Leaders
  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News
  • 11 May 2026
CatSci Achieves ISO 27001 Certification, Demonstrating its Commitment to Client Data Security
  • News
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB